Effect of a histone deacetylase inhibitor on antitumor effect of gemcitabine to focus the gene network of ingenuity pathways analysis. Background: Biliary carcinoma (BC) has a poor prognosis and ...

Oblimersen 1-hour IV infusion in combination with temozolomide and albumin-bound paclitaxel in patients with advanced melanoma. Background: The Src family kinases Fyn, Yes, and Src have variably been ...

As a prelude to combination studies aimed at resistance reversal, this dose-escalation/dose-expansion study investigated the selective Src kinase inhibitor ...

This trial looked at 2 drugs called saracatinib (pronounced sah-rah-cat-in-ib) and paclitaxel (pronounced pak-lit-axe-el) for ovarian cancer. It was for women whose ovarian cancer had come back ...

This trial was to see if a drug called saracatinib could reduce the pain that cancer spread to the bones can cause. This trial was open for people to join between 2014 and 2017, and the team published ...

Please provide your email address to receive an email when new articles are posted on . Saracatinib appeared to be “equal or superior” in stopping fibrotic responses compared with two FDA-approved ...

Share on Pinterest Experts note that atherosclerosis is linked to heart disease risk. Susana Ramírez/Stocksy The medication saracatinib has been researched in the past as a potential cancer treatment.

(Sharecast News) - AstraZeneca announced on Monday that the US Food and Drug Administration (FDA) has granted 'orphan drug designation' for 'saracatinib' - a potential new medicine for the treatment ...

An AstraZeneca drug once studied for use in cancer could have a new lease on life slowing the progression of hardened arteries, new study results suggest. In an article published June 8 in Nature ...

June 8 (UPI) --Preliminary tests of an experimental cancer drug appear to slow inflammation linked to heart disease, giving home for a new therapy, researchers said in a study released Thursday.

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease may slow the progression of atherosclerosis that leads to heart disease, a new study shows. Led ...